TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. - Wikidata - awgldk - TriplyDB

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

http://www.wikidata.org/entity/Q34807008

about

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses Targeting the innate immune system as immunotherapy for acute myeloid leukemia Nucleic acids and endosomal pattern recognition: how to tell friend from foe?Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.Classical Flt3L-dependent dendritic cells control immunity to protein vaccine Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes.Activation of dendritic cells by the novel Toll-like receptor 3 agonist RGC100.Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow.Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge A unique dermal dendritic cell subset that skews the immune response toward Th2 Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators Dendritic cell and macrophage heterogeneity in vivo Transcriptional regulation of dendritic cell diversity.Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells.CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation.Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists TLR agonists are highly effective at eliciting functional memory CTLs of effector memory phenotype in peptide immunization.Regulation of TLR3 Activation by S100A9.Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions.2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors.TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells.Traditional and new influenza vaccines The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.Deciphering the transcriptional network of the dendritic cell lineage Generating a battery of monoclonal antibodies against native green fluorescent protein for immunostaining, FACS, IP, and ChIP using a unique adjuvant Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo Natural killer cell activation secondary to innate pattern sensing.Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

P2860

Q26765446-26314AAF-27A8-4E88-A3D4-91DAFCD09149 Q26777948-9E069EEC-5D20-40C6-99EC-FF45A3AAA4E3 Q27015876-97491E53-5308-4F85-98F6-8D56DD508926 Q27022525-E7E270DB-D5EF-4C0E-A50A-9505E70F324A Q27342989-1421042D-D950-4A88-B3FD-A88DDC622FA4 Q28728791-A4730FEC-D280-4962-9DF4-560D2A466569 Q33909362-D43FF166-A553-42CE-92C3-3B4C509803E4 Q34089167-E38379F7-F563-4949-88D1-7128BC7E3AAF Q34199805-21580A07-A26E-412C-8E7F-E14F503856A7 Q34399608-31EBD0F6-8E17-4437-99BF-BD8D8BEEAC81 Q34520840-60E27416-9FBB-49B1-B30E-75E065AA561A Q34660094-6453D40E-49FD-4D1D-B5E0-9F7155CFD7C2 Q34712969-EC1F97B0-C9D9-41D7-AB92-6A223F08E80C Q34855420-708F953B-1674-4C54-AFD1-29B65E80B36A Q34988945-28F7E2BB-7A86-4444-B061-4033820E7259 Q35301495-EA31AD7E-9A7D-49A6-B336-8016164F1726 Q35691240-C9AA0593-002F-4782-BD08-16EE21E846E5 Q35751039-84BCFBA1-D481-41F7-8DAF-5D104D287BB2 Q35779135-4ACCEBCE-3360-46C3-9BFC-5FCA5CB60E69 Q35826747-E4EB67CA-DB7E-43AE-A270-8C3A0DF0E4C7 Q35903971-37790319-D9D4-4289-A6DD-54CC3AC19E14 Q35927398-4C94CF08-E945-4113-A7A4-F53A1E4E36AE Q36104042-599E4E44-036C-488D-B05B-5D9871565179 Q36194804-F93A5743-9286-4BE4-B66C-425892B1C60E Q36276652-C591F0B3-6AD8-4013-AE70-5B274739404E Q36333494-B24BB7B5-FEA3-4F54-9F89-5EA03ED307A7 Q36508677-7D2BFE21-6FDC-45D4-B617-0C21E0EFC5DA Q36539888-5482AAEF-95BE-46D2-B827-976E23D2D485 Q36561303-73B72313-EA75-4B71-807E-EC9DDD241A73 Q36723438-2917BE8A-61CC-4372-8379-16082F091C39 Q36987499-422B65F3-43BD-4017-ABB1-3EABFE8D7D76 Q37028027-99030ED4-70A6-4C2A-8ACB-BB60F02AFF87 Q37035833-0E091129-F4AD-4A1A-B0C5-4A42AD782A31 Q37294444-CE3DB109-979A-48B1-B795-0BC63EF45B31 Q37700905-07A65231-D41B-4EED-BCEE-7F7B232E419A Q37721510-DC7D23ED-2095-47FB-B732-1BB571068EF1 Q37728326-DF5736D5-469F-4466-A741-46CF84821D7B Q37860087-AC0AB09A-A1A3-47D5-A521-3026EF332763 Q37874330-92AE18E6-2161-4D6E-B658-D3A89C52F7AC Q37997315-4EE2BC96-A298-4439-8DEC-EB7D49FE6EC9

P2860

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

http://www.wikidata.org/entity/Q34807008

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

TLR3-specific double-stranded ...... ses, and antiviral protection.

@ast

TLR3-specific double-stranded ...... ses, and antiviral protection.

@en

TLR3-specific double-stranded ...... ses, and antiviral protection.

@nl

type

label

TLR3-specific double-stranded ...... ses, and antiviral protection.

@ast

TLR3-specific double-stranded ...... ses, and antiviral protection.

@en

TLR3-specific double-stranded ...... ses, and antiviral protection.

@nl

prefLabel

TLR3-specific double-stranded ...... ses, and antiviral protection.

@ast

TLR3-specific double-stranded ...... ses, and antiviral protection.

@en

TLR3-specific double-stranded ...... ses, and antiviral protection.

@nl

P1433

Q34807008-FD6104B5-00B4-4AD1-8DF7-F3F4F7A37FC2

P1476

Q34807008-251D74FB-2B3B-4F11-9F52-A56F7BB93F3E

P2093

Q34807008-101E458C-828D-4358-8FC0-1F30FA292CA5

Q34807008-32454D51-E75D-45A3-9AF1-DCE92C1789BA

Q34807008-5159B209-E24D-45CF-9C04-3F23264BE920

Q34807008-5BEBA907-F505-42A0-9227-19B0C14C1FE7

Q34807008-6552B754-4162-453A-9A19-E49B5F228729

Q34807008-875BBA05-2284-48A3-9A86-26CA507F091B

Q34807008-A48D07D9-8D1C-4536-A0F5-95F584BA052B

Q34807008-AAA159AE-92B8-425F-9D10-541714B4D8A3

Q34807008-C960AA0D-3314-4EA6-8357-4B6BC99E9E17

Q34807008-EBEB9490-8B60-49FC-AB9D-4BE06681A15B

P2860

Q34807008-016CA8E7-CB5E-435D-9299-8984E7065F6E

Q34807008-05A1986A-6B72-4662-82B8-6672FF8C3562

Q34807008-0A05CE0C-6FA4-42EF-B353-371DE6D717B4

Q34807008-0DF26071-D19A-49E5-BD42-E7BF653721C9

Q34807008-0E0782DA-991A-49C8-9E32-77DB9BFF3A16

Q34807008-17FB2778-2344-44BC-94F3-C3EB3C7B34E4

Q34807008-208112AE-7B13-467E-A6C6-D2ACE087540D

Q34807008-2443DC7E-B5C6-4E67-A035-6D84B6EBF4B7

Q34807008-2A7181F6-BE7F-4ACC-AE18-BC00277A4C62

Q34807008-34E8744F-4C33-4C5B-9FE0-9A540A377F7C

P304

Q34807008-A68F3F2B-BEFE-4FE1-A208-AF1E591CA58C

P31

Q34807008-E29E9EB6-F967-4CC8-B20F-268798808ADC

P356

Q34807008-1B2B94A7-6AF4-452E-A8D3-21617C59B0F2

P407

Q34807008-649A4F6E-EC8B-4B70-A0A2-568CF9279599

P433

Q34807008-B9C16979-100F-47EA-BB06-94CE38FA68BC

P478

Q34807008-5F5627FB-D1C6-4304-B910-B96C723FE087

P577

Q34807008-5AD9A23E-B94C-4A29-BF7D-C892C3B17C24

P5875

Q34807008-E97395C7-A2AA-4282-9A44-4DAB2C708405

P698

Q34807008-6780EB25-88F9-4048-A343-4D09135678A5

P921

Q34807008-132CDDA9-7DE2-41C9-A494-93A65837558C

P932

Q34807008-79A831E1-BD98-400A-BD92-C29581672576

P356

JIMMUNOL.1002845

P1433

Journal of Immunology

P1476

TLR3-specific double-stranded ...... ses, and antiviral protection.

@en

P2093

Anna Meyer-Manlapat

http://www.w3.org/2001/XMLSchema#string

David M Segal

http://www.w3.org/2001/XMLSchema#string

David Venzon

http://www.w3.org/2001/XMLSchema#string

Graeme E Price

http://www.w3.org/2001/XMLSchema#string

Ivett Jelinek

http://www.w3.org/2001/XMLSchema#string

Joshua N Leonard

http://www.w3.org/2001/XMLSchema#string

Kevin N Brown

http://www.w3.org/2001/XMLSchema#string

Paul K Goldsmith

http://www.w3.org/2001/XMLSchema#string

Suzanne L Epstein

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen presentation and T cell stimulation by dendritic cells

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Activation of MDA5 requires higher-order RNA structures generated during virus infection

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Dendritic cells and the control of immunity

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.

P304

2422-2429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1002845

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49762667

http://www.w3.org/2001/XMLSchema#string

P698

21242525

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3078629

http://www.w3.org/2001/XMLSchema#string